<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Basilar artery <z:mp ids='MP_0005048'>thrombosis</z:mp> has high morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Though intra-arterial thrombolytics have proven efficacy in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> basilar <z:mp ids='MP_0006134'>artery occlusion</z:mp>, the elevation of procoagulant factors in the blood after intra-arterial thrombolysis could result in subsequent <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and clinical deterioration </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="2" ids="17089">Glycoprotein</z:chebi> IIb/IIIa inhibitors have been shown to reduce this elevation in procoagulants </plain></SENT>
<SENT sid="3" pm="."><plain>We present a pilot study of three cases of <z:hpo ids='HP_0011009'>acute</z:hpo> basilar <z:mp ids='MP_0006134'>artery occlusion</z:mp> treated with a combination of intra-arterial thrombolytics and Gp IIb/IIIa inhibitor with remarkable clinical recovery seen in <z:hpo ids='HP_0000001'>all</z:hpo> the patients </plain></SENT>
</text></document>